Spectrum and surgical outcomes of gastrointestinal stromal tumours

CONCLUSION: Whilst the numbers were small, certain trends were observed. Surgery in combination with imatinib offers survival benefit in patients undergoing R0, R1, R2, liver metastases and multivisceral resections.PMID:36477053 | DOI:10.17159/2078-5151/SAJS3721

Source: South African Journal of Surgery - December 8, 2022 Category: Surgery Authors: M S A Sithole F G Madela T N Buthelezi-Zulu T Lusu K Mody N E Nyakale V Pillay B P Hadebe F Anderson Source Type: research